Cytogenetics redemonstrated one complex abnormal clone associated with systemic mastocytosis/MCL and a second independent myeloid neoplasm with high-risk features, including loss of 5q and biallelic loss of 17p (TP53). The gene discussed is TP53; the disease is mantle cell lymphoma.